These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24716857)

  • 1. Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ.
    Zhou X; Ringseis R; Wen G; Eder K
    Acta Vet Scand; 2014 Apr; 56(1):21. PubMed ID: 24716857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells.
    Zhou X; Wen G; Ringseis R; Eder K
    J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-inflammatory cytokine tumor necrosis factor α stimulates expression of the carnitine transporter OCTN2 (novel organic cation transporter 2) and carnitine uptake via nuclear factor-κB in Madin-Darby bovine kidney cells.
    Zhou X; Ringseis R; Wen G; Eder K
    J Dairy Sci; 2015 Jun; 98(6):3840-8. PubMed ID: 25892691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the human, porcine and bovine OCTN2 gene by PPARα via a conserved PPRE located in intron 1.
    Luo H; Zhang Y; Guo H; Zhang L; Li X; Ringseis R; Wen G; Hui D; Liang A; Eder K; He D
    BMC Genet; 2014 Sep; 15():90. PubMed ID: 25299939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
    D'Argenio G; Petillo O; Margarucci S; Torpedine A; Calarco A; Koverech A; Boccia A; Paolella G; Peluso G
    J Biol Chem; 2010 Aug; 285(35):27078-27087. PubMed ID: 20558736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.
    Sanderson LM; Boekschoten MV; Desvergne B; Müller M; Kersten S
    Physiol Genomics; 2010 Mar; 41(1):42-52. PubMed ID: 20009009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha.
    Maeda T; Wakasawa T; Funabashi M; Fukushi A; Fujita M; Motojima K; Tamai I
    Biol Pharm Bull; 2008 Jun; 31(6):1230-6. PubMed ID: 18520060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
    Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
    Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
    Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
    Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues.
    Luci S; Hirche F; Eder K
    Ann Nutr Metab; 2008; 52(1):58-67. PubMed ID: 18309235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
    Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Δ
    Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
    Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.